Pharmaceutical Industry

Drug Development Drug Pricing Market Competition Drug Manufacturing Market Trends Drug Manufacturers Market Dynamics Manufacturing Pricing Strategies Vaccine Development

FDA Upgrades Children’s Ibuprofen Recall to Class II Over Reports of Foreign Material

Reports of gel-like material, including black particles, in two nationwide lots triggered the FDA’s action.

FDA Approves First Therapy for Acquired Hypothalamic Obesity, Expanding Rhythm’s Imcivree

Novartis Strikes $2 Billion Deal for Mutant-Selective PI3Kα Cancer Drug SNV4818

Stories older than 24h

FDA Clears 7.2‑mg Wegovy as India Enters Generic Semaglutide Era

FDA Clears J&J’s Icotyde, First Oral IL-23 Psoriasis Therapy for Ages 12 and Up

India Braces for 50+ Semaglutide Generics as Patent Expires Friday

Drug-Cost Anxiety Hits New High in KFF Poll as TrumpRx Sees Limited Reach

Lilly Urges Recall After Finding New Impurity in Compounded Tirzepatide With B12

FDA Warns Novo Nordisk Over Missed Reporting of Serious Semaglutide and GLP-1 Adverse Events

Trump Promotes Drug-Price Push and Reshoring on Cincinnati-Area Swing, Backs Massie Challenger

Vertex’s IgA Nephropathy Drug Hits Phase 3 Goals, FDA Filing Slated for March

C-Further Launches First Pediatric Cancer Programs, Taps MiNK for PRAME iNKT Therapy

Xenon to Present Topline X-TOLE2 Phase 3 Results in Focal Onset Seizures at 8 A.M. ET Today

FDA Approves Sotyktu for Active Psoriatic Arthritis as First TYK2 Inhibitor

Servier to Acquire Day One Biopharma in $2.5 Billion All-Cash Deal at $21.50 a Share

Japan Grants Conditional Approval to First iPS Cell Therapies for Parkinson’s and Heart Failure

FDA Demands Placebo-Controlled Trial for UniQure’s Huntington’s Gene Therapy

Zealand Plunges as Roche Obesity Drug Posts 10.7% Weight Loss With Placebo‑Like Tolerability

FDA Approves Teclistamab–Daratumumab Combination for Relapsed Multiple Myeloma After One Prior Therapy

Indian National Sentenced to 43 Months for Counterfeit Keytruda Scheme